CAR-T Cells: Navigating the Landscape of Access, Sustainability, and Innovation - A Dialogue Between Prof. Robin Foà and Dr. Filippo Milano

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/6d/0e/be/6d0ebe06-0086-f178-f913-75ebfef5db1f/mza_1013507527412833612.jpg/600x600bb.jpg

Hematology Pills

Mattioli Health

9 episodes

1 week ago

Hematology Pills is a new format based on monthly discussions between Prof. Robin Foà (Rome) and Dr. Filippo Milano (Seattle). Each episode explores the latest breakthroughs in gene therapy, immunotherapy, and clinical innovation, while addressing also ethical and practical challenges that shape the field. Our podcast offers a clear and compelling look at the evolving landscape of blood disorders and treatments for hematologists, researchers and healthcare professionals. Stay informed, inspired, and connected with Hematology Pills – a source off hematology updates, one episode at a time.

Medicine

Health & Fitness

RSS

All content for Hematology Pills is the property of Mattioli Health and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/43074747/43074747-1739953567941-05645e7877ada.jpg

CAR-T Cells: Navigating the Landscape of Access, Sustainability, and Innovation - A Dialogue Between Prof. Robin Foà and Dr. Filippo Milano

Hematology Pills

20 minutes 45 seconds

8 months ago

CAR-T Cells: Navigating the Landscape of Access, Sustainability, and Innovation - A Dialogue Between Prof. Robin Foà and Dr. Filippo Milano

Join Prof. Robin Foà (Sapienza University of Rome) and Dr.Filippo Milano (Fred Hutchinson Cancer Center, Seattle) as they explore the evolving landscape of CAR-T cell therapies. This episode of Hematology Pills offers concise yet profound insights into the challenges and opportunities surrounding CAR-T treatments, from access and sustainability to innovation and clinical advancements.With a focus on real-world applications, the discussion highlights key issues such as treatment accessibility, cost-effectiveness, long-term outcomes, and the future of CAR-T in autoimmune diseases.